[An innovative laser for the minimally invasive treatment of benign prostatic hyperplasia]

In an aging population, the number of patients suffering from benign prostatic hyperplasia is increasing. Furthermore, this older part of the population often bears multiple co-morbidities requiring permanent anticoagulation or antiaggregration medication. This has led to encourage the development of new surgical techniques. Photovaporization of the prostate (PVP) in particular provides improved hemostasis, and allow to operate patients without interrupting anticoagulation therapy. Functional results of PVP with a medium-term followup are similar to the current standards of transurethral resection of the prostate (TURP). Finally, PVP allows a significantly shorter hospital stay than TURP.